Back to top

MYGN Crosses Above Average Analyst Target

In recent trading, shares of Myriad Genetics, Inc. (MYGN) have crossed above the average analyst 12-month target price of $7.42, changing hands for $7.68/share..

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Myriad Genetics, Inc. (MYGN)